Search hospitals > Iowa > Iowa City
University of Iowa Children's Hospital
Claim this profileIowa City, Iowa 52242
Global Leader in Myelodysplastic Syndrome
Global Leader in Duchenne Muscular Dystrophy
Conducts research for Post-Traumatic Ataxia
Conducts research for Brachydactyly Nystagmus Cerebellar Ataxia Syndrome
Conducts research for Friedreich Ataxia
60 reported clinical trials
2 medical researchers
Summary
University of Iowa Children's Hospital is a medical facility located in Iowa City, Iowa. This center is recognized for care of Myelodysplastic Syndrome, Duchenne Muscular Dystrophy, Post-Traumatic Ataxia, Brachydactyly Nystagmus Cerebellar Ataxia Syndrome, Friedreich Ataxia and other specialties. University of Iowa Children's Hospital is involved with conducting 60 clinical trials across 139 conditions. There are 2 research doctors associated with this hospital, such as Katherine Mathews, MD and Polly Ferguson, MD.Area of expertise
1Myelodysplastic Syndrome
Global Leaderexon 53 skipping amenable deletion positive
exon 45 skipping amenable deletion positive
2Duchenne Muscular Dystrophy
Global Leaderexon 53 skipping amenable deletion positive
exon 45 skipping amenable deletion positive
Top PIs
Katherine Mathews, MDUniversity of Iowa Hospitals and Clinics1 year of reported clinical research
Studies Myelodysplastic Syndrome
Studies Duchenne Muscular Dystrophy
16 reported clinical trials
14 drugs studied
Polly Ferguson, MDUniversity of Iowa Stead Family Children's Hospital3 years of reported clinical research
Studies Psoriatic Spondylitis
Studies Ankylosing Spondylitis
1 reported clinical trial
3 drugs studied
Clinical Trials running at University of Iowa Children's Hospital
Acute Myeloid Leukemia
Adult T-Cell Leukemia/Lymphoma
Myeloid Leukemia
Acute Myelogenous Leukemia
Sanfilippo Syndrome
Mucopolysaccharidosis
Sanfilippo syndrome
Venetoclax + Chemotherapy
for Acute Myeloid Leukemia
This trial is testing whether adding venetoclax to standard chemotherapy can help young patients with relapsed AML. Venetoclax works by blocking a protein that helps cancer cells survive, making it easier for the chemotherapy to kill them. The study aims to find better treatment options for these patients who have limited choices. Venetoclax has been shown to improve overall survival in older and unfit patients with newly diagnosed acute myeloid leukemia when combined with lower intensity therapies.
Recruiting2 awards Phase 34 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Iowa Children's Hospital?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.